Skip to main content

Federica Rizzo

Institutions of which they are part

Predoctoral researcher
Stroke research
Vall Hebron Institut de Recerca

Federica Rizzo

Institutions of which they are part

Predoctoral researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

PREDICTHOR: Predicción y mejora del resultado funcional en pacientes con ictus subagudo/crónico a través de telerehabilitación a domicilio basada en realidad virtual no invasiva

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Noelia Rodríguez Villatoro, Federica Rizzo
Funding agency: Instituto de Salud Carlos III
Funding: 158750
Reference: PI23/01680
Duration: 01/01/2024 - 31/12/2026

Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Carlos Molina Cateriano, Federica Rizzo
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 437334
Reference: CPP2021-008378
Duration: 01/03/2022 - 28/02/2025

Ministerio de Ciencia

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Judith Cendrero Correa, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

TRUSTroke: TRUSTWORTHY PREDICTION OF STROKE OUTCOME ON A FEDERATED LEARNING INFRASTRUCTURE

IP: Carlos Molina Cateriano
Collaborators: Estela Sanjuan Menendez, Laura Rivera Sanchez, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Bastien Debieve
Funding agency: EUROPEAN COMMISSION
Funding: 760000
Reference: TRUSTROKE_HE-HLTH-STAYHLTH2022
Duration: 01/05/2023 - 30/04/2027

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Andrea Freixa Benavente

Andrea Freixa Benavente

Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Gemma  Duarri Llado

Gemma Duarri Llado

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Jordi Masiá Gridilla

Jordi Masiá Gridilla

Predoctoral researcher
New Technologies and Craniofacial Microsurgery
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.